One of a crop of new direct-to-consumer, hipster-branded startups, Hims sells ED and hair-loss drugs and plans to branch out into other meds.
The future of health, and the business of getting there
The Future of Medicine
Data & Disruption
Employers are questioning a system they say costs patients too much.
The Business of Drugs
Patients, Profits & Policy
Novartis CEO Says It's `Prudent' to Pull Back From Further Price Increases
Novartis AG Chief Executive Officer Vas Narasimhan talks about U.S. drug pricing, government health-care policy and plans to spin off the Swiss drugmaker's Alcon eye-care unit. He speaks from Basel, Switzerland, on "Bloomberg Daybreak: Europe" after profit beat estimates in the second quarter, allowing Novartis to reiterate its full-year forecast. (Source: Bloomberg)
J&J CFO Says 2Q Results 'Not Related to Trade Wars'
Brett Kavanaugh's Artful Dodge
Why J&J Investors Aren't So Concerned About $4.69B Talc Verdict
J&J Shares Slip as Investors Assess Loss From Talc Legal Saga
In Case You Missed It
Investors point to China’s health care sector as the possible birthplace of its next juggernauts.
A billionaire and his very powerful computer are helping a pharma pioneer find the drugs of tomorrow.
The drugmaker won't raise drug prices until … the next time it usually increases them. Truly heroic.